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Abstract
Elevated low-density lipoprotein (LDL)-cholesterol is a risk factor for both Alzheimer’s disease (AD) and Atherosclerosis
(CVD), suggesting a common lipid-sensitive step in their pathogenesis. Previous results show that AD and CVD also share a
cell cycle defect: chromosome instability and up to 30% aneuploidy–in neurons and other cells in AD and in smooth muscle
cells in atherosclerotic plaques in CVD. Indeed, specific degeneration of aneuploid neurons accounts for 90% of neuronal
loss in AD brain, indicating that aneuploidy underlies AD neurodegeneration. Cell/mouse models of AD develop similar
aneuploidy through amyloid-beta (Aß) inhibition of specific microtubule motors and consequent disruption of mitotic
spindles. Here we tested the hypothesis that, like upregulated Aß, elevated LDL/cholesterol and altered intracellular
cholesterol homeostasis also causes chromosomal instability. Specifically we found that: 1) high dietary cholesterol induces
aneuploidy in mice, satisfying the hypothesis’ first prediction, 2) Niemann-Pick C1 patients accumulate aneuploid
fibroblasts, neurons, and glia, demonstrating a similar aneugenic effect of intracellular cholesterol accumulation in humans
3) oxidized LDL, LDL, and cholesterol, but not high-density lipoprotein (HDL), induce chromosome mis-segregation and
aneuploidy in cultured cells, including neuronal precursors, indicating that LDL/cholesterol directly affects the cell cycle, 4)
LDL-induced aneuploidy requires the LDL receptor, but not Aß, showing that LDL works differently than Aß, with the same
end result, 5) cholesterol treatment disrupts the structure of the mitotic spindle, providing a cell biological mechanism for
its aneugenic activity, and 6) ethanol or calcium chelation attenuates lipoprotein-induced chromosome mis-segregation,
providing molecular insights into cholesterol’s aneugenic mechanism, specifically through its rigidifying effect on the cell
membrane, and potentially explaining why ethanol consumption reduces the risk of developing atherosclerosis or AD.
These results suggest a novel, cell cycle mechanism by which aberrant cholesterol homeostasis promotes
neurodegeneration and atherosclerosis by disrupting chromosome segregation and potentially other aspects of
microtubule physiology.
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Introduction
High levels of dietary cholesterol and plasma LDL have been
found to constitute a common risk factor for both atherosclerosis/
cardiovascular disease and for Alzheimer’s disease, but the
mechanism(s) of this effect are incompletely understood [1,2].
Atherosclerosis is characterized by localized accumulations of
lipids, inflammatory cells, smooth muscle cells and calcified cell
debris [3], while Alzheimer’s disease (AD) is characterized by
aberrant oligomerization/polymerization of two misfolded pro-
teins–extracellular amyloid-beta (Aß) assembled into amyloid
deposits, and intracellular hyperphosphorylated tau assembled
into neurofibrillary tangles [4–6]. We sought to determine whether
there is a common pathogenic pathway by which cholesterol/LDL
promotes the development of both atherosclerosis and Alzheimer’s
disease.
Genetic, biochemical, and transgenic mice studies of mutations
that cause familial forms of AD (FAD) have identified the Aß
peptide as central to AD pathogenesis, with Apolipoprotein E
(ApoE), Tau, and microtubules being required for Aß to
oligomerize/polymerize and induce synaptic loss, neurodegener-
ation, and dementia [4–7].
Cell Cycle Defects and Chromosome Mis-segregation in
AD
One mechanism by which Aß evidently causes neurodegener-
ation is by interfering with cell cycle. For example, we proposed
that AD subjects would exhibit chromosome mis-segregation and
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the accumulation of aneuploid, particularly trisomy 21 cells and
then used primary skin fibroblasts to demonstrate such trisomy 21
mosaicism and a trend toward chromosome 18 mosaicism in both
familial and sporadic AD (SAD) patients [8–11]. AD lymphocytes
also showed trisomy 21 mosaicism and premature centromere
division, a mechanistic precursor to chromosome mis-segregation
[9,12–16]. Work from several laboratories confirmed and extend-
ed these results to buccal cells and brain neurons, with trisomy 21
constituting 10% of neurons in late stage AD brain [17–21].
We investigated the mechanism of this cell cycle defect and
found that mutations in the presenilin 1 (PS1) and amyloid
precursor protein (APP) genes that cause FAD directly induce
chromosome mis-segregation and up to 20% aneuploidy in
lymphocytes and neurons of transgenic mice and in transfected
cells. Indeed the Alzheimer Aß peptide, the proteolytic product of
the PS1 based c-secretase enzyme on the APP protein and the key
player in AD pathogenesis, also induces abnormal spindle
structure and chromosome mis-segregation, including human
trisomy 21 and mouse trisomy 16 in transgenic mice, transfected
cells, and cell-free Xenopus egg extracts [22–24,25–28]. We found
that his profound defect in mitosis in AD results from Aß
inhibition of certain mitotic kinesin motor proteins, including
kinesin5/Eg5, that are essential for the structure and function of
the mitotic spindle [24].
That chromosome mis-segregation and the consequent devel-
opment of aneuploidy plays an essential role in AD pathogenesis is
indicated by the finding that following the development of 30%
aneuploid neurons during the early stages of AD, the specific loss
of these aneuploid neurons in the transition from mild cognitive
impairment to late stage AD can account for 90% of the neuronal
cell loss observed at autopsy [21].
The finding of trisomy 21 mosaicism in AD is particularly
interesting because of the universal presence of AD-like pathology
and neurodegeneration in full trisomy 21 Down syndrome (DS)
patients [8,29–31], and the finding that early onset inherited AD
can be caused by a single duplicated APP gene on one
chromosome 21 [32,33]. Evidently a 50% excess of APP and its
product Aß are sufficient for the development of AD. Case studies
of patients with trisomy 21 mosaicism and no intellectual
impairments of the DS type who developed AD by age 40
demonstrates that a small percentage of trisomy 21 cells can, over
a lifetime, lead to and/or contribute to the pathogenesis of AD
[8,25,34–37].
Disruption of Cholesterol Homeostasis in
Neurodegenerative Diseases
Because the generation and loss of aneuploid neurons appears
to underlie the majority of AD neurodegeneration, it is essential to
understand the mechanism by which such aneuploidy arises
during the preclinical stage of the disease. Clearly, the overpro-
duction of the Aß peptide may be partly responsible. However,
defects in cholesterol homeostasis may also play a role in AD
pathogenesis [38–43]. For example AD, and cardiovascular
disease (CVD) share risk factors (e.g., high plasma cholesterol
and a high cholesterol and/or saturated fat diet), and the severity
of atherosclerotic lesions in AD brains correlates with the extent of
AD pathology [38,40]. Likewise, FAD transgenic mice fed a high
cholesterol diet develop accelerated amyloid burden and steeper
cognitive decline compared to animals on regular chow [39,43].
Conversely, inhibition of endogenous cholesterol synthesis with
statins has been associated with a reduced risk of AD and
decreased amyloid deposits in humans and animals [42]. Finally,
ApoE is the major cholesterol transporter in the brain, and
inheritance of the ApoE e4 allele is the strongest genetic risk factor
for sporadic AD [44]. ApoE particularly ApoE4 directly associates
with Aß and catalyzes its polymerization into neurotoxic
assemblies [7].
A dysregulation of cholesterol homeostasis has also been
implicated in other chronic neurodegenerative diseases, including
Niemann-Pick (NPC), Huntington, and Parkinson’s disease
[39,43]. Specifically, a direct association between disrupted
intracellular cholesterol trafficking and consequent neuronal loss,
gliosis, and formation of neurofibrillary tangles (NFT) in individ-
uals carrying a mutation in the NPC1 or NPC2 gene has been
established. Loss-of function mutations in these genes cause
sequestration of unesterified cholesterol in late endosomes/
lysosomes in a number of cells and tissues, but are most deleterious
for brain development and health, triggering progressive neuro-
pathology, ataxia, dementia and premature death in early
adolescence [43]. Recent studies utilizing human samples and
cellular and animal models of NPC revealed interesting parallels
between AD and NPC neuropathogenesis, which include
endosomal/lysosomal dysfunction, glial-mediated inflammation,
NFTs and Aß accumulation especially in ApoE e4 carriers,
cholesterol dyshomeostasis, and cell cycle reactivation
[27,28,39,43]. However, unlike AD [8–21], the presence of
chromosomal abnormalities such as aneuploidy in peripheral
and brain cells has not been reported in NPC.
These pathological correlations and our finding that Aß induces
chromosome mis-segregation prompted us to investigate whether
cholesterol might also induce aneuploidy in AD and possibly NPC
and atherosclerosis. The latter hypothesis was reinforced by
reports that each atherosclerotic plaque harbors a monoclonal
proliferation of aneuploid smooth muscle cells [45–52].
To test these hypotheses, we asked whether cholesterol and
lipoproteins induce chromosomal mis-segregation in vivo and
in vitro and then investigated the mechanism of their observed
novel aneugenic effect.
Results
To investigate whether lipoproteins and cholesterol affect
chromosome segregation, we approached the project in three
phases. First, metaphase chromosome analysis and fluorescence in
situ DNA hybridization (FISH) were used to determine whether
LDL/cholesterol increases the levels of total and chromosome
specific aneuploidy in vivo: in mice fed a high cholesterol diet and
in human Niemann-Pick patients with a mutation in the NPC1
gene, which is implicated in cholesterol trafficking and athero-
sclerosis but has not previously been associated with a defect in
chromosome segregation, although mitosis-specific epitopes have
been observed in NCP1 brains [53,54] (Figure 1,2). Then, to
establish that lipoproteins/cholesterol were directly responsible for
the aneuploidy we observed in cholesterol-fed mice and NPC1
patients, we analyzed the chromosomes of different cells in culture
after exposure to various lipids, including water solubilized
cholesterol (Figures 3–4). Particular attention was paid to assessing
the aneuploidy of chromosomes 7, 12, 14, 18 and 21, as mis-
segregation of several of these chromosomes has been found in AD
[9,11–23] and in atherosclerotic lesions [46–51]. We then
investigated the mechanism by which lipoproteins/cholesterol
induce chromosome mis-segregation by analyzing their effect in
cells lacking the low density lipoprotein receptor (LDLR) or the
APP gene or exposed to calcium chelators or ethanol to counter
the intracellular signaling and the membrane rigidifying effect of
cholesterol (Figures 5–8). Finally we determined whether choles-
terol treatment induces DNA damage (Figure 9) or disrupts the
mitotic spindle, for example leading to multiple centrosomes
Cholesterol and Chromosome Mis-Segregation
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(MOCs), lagging chromosomes and mis-aligned/displaced DNA
or disarrayed microtubules, all of which are known causes of
chromosome mis-segregation/instability (Figure 10).
Cholesterol Dyshomeostasis Induces Aneuploidy in vivo
Mice fed a high cholesterol diet develop aneuploidy in
splenocytes. The effect of hypercholesterolemia on chromo-
some-segregation in peripheral cells (T-splenocytes) and in brain
cells was assessed in atherosclerosis-susceptible wild-type mice, the
C57BL/6 strain [55]. One-month-old (nontransgenic) mice (4
males and 4 females) were randomly assigned to normal mouse
chow (0% cholesterol) or a high cholesterol (,1.05%) diet (two
mouse pairs per group) for 12 weeks. Mice fed the regular diet
consumed on average 50.6268.34 g/mouse pair/week
(,172 Kcal of Digestible Energy (DE)/mouse pair/week), while
mice on the high cholesterol diet consumed on average
50.83611.14 g/mouse pair/week (,229 Kcal of DE/mouse
pair/week). Because of the difference in caloric value between
the diets, mice on the high cholesterol diet gained on average 2K
times more weight than mice fed regular chow (p,0.05).
Pathological examination at sacrifice confirmed that only mice
on the high cholesterol diet developed hepatic steatosis, a sign of
dyslipidemia, which was confirmed with Oil-Red-O staining of
isolated hepatocytes (Figure 1A).
Primary splenocyte cultures and brain cell suspensions from
mice on the regular and atherogenic diets were analyzed for
aneuploidy. FISH analysis of concanavalin A-stimulated spleen T-
cells from mice fed the high cholesterol diet showed a significant
increase in trisomy 16 compared to T-splenocytes of mice fed the
regular diet (Fig. 1B,C), but there was no induction of aneuploidy
in brain cells (0.76% versus 0.65%, p = 0.3). The fact that diet-
induced hypercholesterolemia has not been reported to affect
brain cholesterol homeostasis in wild-type mice suggests that
serum cholesterol may have induced the spleen cell aneuploidy
while sparing the brain. It is also possible that 12 weeks is sufficient
time to induce the development of aneuploid cells in mitotically
active peripheral (lymphatic) tissues of animals fed cholesterol, but
is insufficient to allow accumulation of significant aneuploidy in
the brain resulting from relatively less active neurogenesis.
Figure 1. Increased cholesterol induces chromosome aneuploidy in vivo. (A) Mouse hepatocytes (hematoxylin blue stain; light gray in
micrograph) were stained with Oil-Red-O stain (red stain, dark gray in micrograph) to detect accumulation of lipid droplets, a sign of liver steatosis
and a consequence of dyslipidemia in mice fed a high cholesterol diet (right panel). (B–C) Quantitative FISH analysis for chromosome 16 showed that
young wild-type mice fed a high (1.05%) cholesterol, atherogenic diet for 12 weeks developed higher levels of trisomy 16 in spleen cells compare to
mice fed regular chow.
doi:10.1371/journal.pone.0060718.g001
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Niemann-Pick (NPC1) mutant neurons, glia, and
fibroblasts accumulate elevated levels of trisomy 21. To
investigate the role of disrupted peripheral and central cholesterol
homeostasis in chromosome segregation in a longer-term human
neurodegenerative disease model, we turned to primary cells
derived from patients diagnosed with Niemann-Pick Type C
(NPC) disease (Table 1). Mutations and deletions in the NPC1 and
NPC2 genes cause impaired trafficking of unesterified cholesterol
(both low density lipoprotein receptor (LDLR)-internalized and
endogenously synthesized) and other lipids (e.g., glycosphingolip-
ids), which accumulate in late endosomes and lysosomes and fail to
travel to the plasma membrane and endoplasmic reticulum (ER),
resulting in severe cognitive deficits [56,57]. Loss/defect in the
NPC1 gene has also been shown to promote atherosclerosis in
animal models [58]. Interestingly, as was first reported in AD,
mitosis-specific proteins and/or phospho-epitopes have been
found to be upregulated in NPC1 brains [27,28,53,54,59–65].
To test whether cholesterol mal-distribution affects chromosome
stability in NPC disease, we assessed the level of aneuploidy in
primary NPC fibroblasts and brain cells hybridized with FISH
probes for chromosomes 12, 21, 14 and/or 18. We observed a 4-
fold increase in trisomy 21 in NPC1 fibroblasts (Figure 2A,B)
compared to normal fibroblasts and an increase of aneuploidy 12
that did not reach statistical significance (2.1% versus 0.4%,
p = 0.12). Quantitative FISH analysis of Neu-N-positive and Neu-
N-negative brain cells showed 4 to 6-fold increases in trisomy 21 in
both neurons and glia with the NPC1 mutation, compared to the
cells from control brains (Fig. 2C,D). However, there was no
increase in aneuploidy of chromosomes 12, 14 or 18 in NPC brain
cells compared to controls (0.55% vs. 0.24%, p = 0.11; 1.61% vs.
1.46%, p = 0.41; and 0.75% vs. 0.78%, p = 0.45, respectively).
These results are the first demonstration of a genomic instability
and trisomy 21 mosaicism in Niemann-Pick disease and indicate
that a cholesterol accumulation/localization defect causes chro-
mosome mis-segregation in humans, as a high cholesterol diet did
in mice.
Lipoprotein/cholesterol Induces Aneuploidy in vitro
hTERT-HME1 cells treated with lipoproteins develop
aneuploidy. To determine whether the aneuploidy observed in
NPC patients or in mice fed an atherogenic diet reflects a direct
effect of lipids on mitosis, hTERT-HME1 cells were exposed to
Figure 2. Increased trisomy 21 aneuploidy in fibroblasts and in glia and neurons of Niemann-Pick C1 patients. (A,B) FISH analysis with
a DNA probe for chromosome 21 (red) and chromosome 12 (green) of fibroblasts derived from NPC1 patients (NPC1-HF) showed an increase in
trisomy 21 cells compared to age-matched normal human fibroblasts. (C,D) Quantitative FISH analysis with a DNA probe for chromosome 21 (red)
followed by staining with NeuN antibody (green) and DAPI (blue) of resuspended cells from frontal cortices of control and NPC brains revealed
significantly higher levels of trisomy 21 in NPC neurons and glia compared to controls.
doi:10.1371/journal.pone.0060718.g002
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20 mg/ml oxidized LDL (OX-LDL), LDL or high density
lipoprotein (HDL) for 48 hr and assessed for aneuploidy by
metaphase chromosome analysis and FISH, as described. This
lipid concentration was chosen to mimic the cholesterol level in
human blood and to approximate tissue culture conditions. The
results showed an up to 4-fold increase in abnormal chromosome
complements (20% aneuploidy) in OX-LDL and LDL treated cells
compared to controls and to HDL-treated cells (Figure 3A). The
chromosome specific aneuploidy was further analyzed by quan-
titative FISH (Figure 3B–E), which revealed an induction of: 1)
trisomy 21 and 12 by OX-LDL and a borderline significant
induction of trisomy 21 and 12 by LDL (Figure 3B and D), and 2)
induction of tetrasomy 21 and 12 by both OX-LDL and/or LDL
(Figure 3C and E).
A small number of tetraploid neurons has been observed in AD
brains of humans and mice and interpreted to be a consequence of
aberrant cell cycle activation and DNA duplication without cell
cycle completion [25,27,28,59–65]. The OX-LDL and LDL
induced tetrasomy we observed in interphase hTERT-HME1 cells
are most consistent with severe chromosome mis-segregation
because very few tetraploid/polyploid cells were observed in the
metaphase spreads (Figure 3F), which was determined by counting
a total number of metaphase hyperploid/polyploid cells (having at
least $90 chromosomes) and diploid cells (46 chromosomes [2 n])
in the portion of the slide initially analyzed for karyotype. Also,
individual cells with both tetrasomy 21 and 12 occur at similar
levels in treated and untreated cells (Figure 3E). Similarly in AD
brain, many (10X) fewer tetraploid (4 n) neurons are observed
compared to aneuploid (.2 n and ,4 n) neurons [21].
LDL- induced trisomy 7 in HASM cells. To investigate the
potential role of elevated lipoproteins on chromosome segregation
during atherosclerosis, we tested the aneugenic effect of LDL, OX-
LDL, and HDL (20 mg/ml) for 48 hr on primary human aortic
smooth muscle cells (HASMC), which are prone to trisomy 7 in
atherosclerotic plaques. Quantitative FISH revealed a statistically
significant 3-fold increase in trisomy 7 in LDL treated cells
(Figure 4).
Requirement for LDLR and APP in LDL-induced
chromosome mis-segregation. 1. Lipoprotein induced aneu-
ploidy is dependent of LDLR. The LDL receptor belongs to a large
family of structurally and functionally related cell surface receptors
that are involved in diverse cellular functions, some implicated in
AD pathogenesis, including cholesterol uptake and metabolism,
ApoE binding [66], and APP trafficking and processing [67,68].
More than 1000 unique LDLR genetic alterations have been
identified that lead to Familial Hypercholesterolemia (FH), causing
three to four times higher levels of blood LDL cholesterol than
normal and premature CVD events, including severe atheroscle-
rosis [69].
To investigate whether lipoprotein-induced chromosome mis-
segregation requires a functional LDLR, FH primary human
fibroblasts harboring mutations in both LDLR alleles and normal
human fibroblasts were treated with 20 mg/ml of lipoproteins for
48 hr and assessed for aneuploidy. Quantitative FISH analysis
revealed that LDL-treated normal human fibroblasts develop
significantly higher levels of trisomy 7 compared to LDL-treated
FH fibroblasts (Figure 5A).
2. Lipoprotein induced aneuploidy is independent of APP.
Previously we found that Aß-induced aneuploidy is dependent on
Table 1. Characteristics of the Niemann-Pick Type C (NPC) and Control Samples.
Repository # Age yr Gender Clinical Dx Mutation of NPC assay
Control fibroblasts
AG02101 27 female none N/A
AG02603 35 female none N/A
AG09319 24 female none N/A
AG09429 25 female none N/A
NPC1 fibroblasts
GM18422 NK female NPC1 813_815delCAT & ASP874VAL
GM18390 NK female NPC1 ASP242HIS & SER940LEU
GM22871 4 female NPC1 1920delG & IVS9–1009G.A
GM17912 19 female NPC1 PRO1007ALA & THR1036MET
Control brains
UMB754 11.5 female asthma N/A
UMB1864 2.5 female streptococcus infection N/A
UMB4725 32.2 female hypertension N/A
UMB55 19.6 female auto accident injury N/A
UMB4590 20.5 female dilated cardiomyopathy N/A
NPC brains
UMB5372 11.3 female NPC1 filipin & cholesterol esterification
UMB4214 32.3 female NPC confirmed NPC neuropathology
UMB4237 19.8 female NPC confirmed NPC neuropathology
UMBM4992M 20.1 female NPC NPC clinical diagnosis
yr = year; NK = not known. Human fibroblasts were purchased from Coriell and brains from NICHD Brain and Tissue Bank for Developmental Disorders. Independent T-
test revealed no age difference between NPC and control brain donors (20.968.6 vs. 17.3611.1, p = 0.61).
doi:10.1371/journal.pone.0060718.t001
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endogenous APP, possibly as a cell surface receptor to aid APP
endocytosis and generation of intracellular Aß peptide or for the
uptake of extracellular Aß [23,70,71].
To determine whether lipoprotein/cholesterol and Aß-
induced chromosome mis-segregation are mechanistically relat-
ed, we isolated primary splenocytes from APPKO mice and
nontransgenic littermates, exposed them to lipoproteins, and
scored them for chromosome 16 aneuploidy (Figure 5B). OX-
LDL and LDL induced significant increases in trisomy 16 in
both cell types, indicating that the aneugenic effect of
lipoproteins is independent of APP expression and Aß
production.
Lipids and Cholesterol-induced Aneuploidy and Spindle
Defects are Mediated through Membrane Fluidity and
Calcium Homeostasis
Water-Soluble Cholesterol (WsCh) induces aneuploidy
in vitro. 1. WsCh induces aneuploidy in hTERT-HME1 cells.
Cholesterol, the most abundant lipid in eukaryotic cell membranes
[72], is compartmentalized into microdomains (e.g., lipid rafts),
Figure 3. Lipoprotein treatment induces aneuploidy. (A) Actively growing hTERT-HME1 cells were treated with 20 mg/ml of OX-LDL, LDL or
HDL for 48 hr, arrested in metaphase and Giemsa stained for karyotype analysis. All lipids induced significantly higher levels of aneuploidy compared
to untreated cells, with LDL and or OX-LDL exhibiting a much stronger aneugenic effect than HDL. (B–E) FISH analysis of the same lipoprotein-treated
cells showed that OX-LDL-induced trisomy 21 and trisomy 12 (B,D), and that both OX-LDL and LDL-induced tetrasomy 21 and 12 (C,E). (F) Karyotype
analysis of an aliquot of the cells from the same treatment showed very few, but equal numbers of polyploid cells, indicating that the tetrasomies
observed are due to chromosome mis-segregation of chromosomes 21 or 12, and not a result of chromosome duplication before cell division.
doi:10.1371/journal.pone.0060718.g003
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where it is required for essential cellular functions and structure,
including signal transduction and plasma membrane dynamics
[73,74].
As indicated above, LDLR is used by cells to internalize
external lipoproteins and is clearly required for the aneugenic
effect of LDL. Methyl-b-cyclodextrin, MbCD, as cholesterol
acceptor has been used to modify cellular cholesterol content, and
to aid the delivery of hydrophobic cholesterol into the plasma
membrane and intracellular compartments by enclosing it into its
hydrophobic cavity, bypassing the need for an LDL receptor
[75,76]. To directly examine the effect of cholesterol on
chromosome segregation, we exposed hTERT-HME1 cells to a
water-soluble MbCD:cholesterol complex (WsCh) and performed
karyotype and FISH analysis. First, we conducted a set of
preliminary experiments with the concentrations of 2 to 10 mg/ml
of WsCh for 24 and 48 hr of incubation to determine the optimal
concentration at which aneuploidy induction could be measured
over the background, but no visible morphological changes or
cytotoxicity could be detected. 4 mg/ml of cholesterol exposure
(but not 2 mg/ml) for 48 hr induced a 2-fold increase in total
aneuploidy compared to untreated cells (Figure 6A) and a
significant increase in trisomy 21 and trisomy 12 (Figure 6B),
without altering cell proliferation (p = 0.25). Taken together, these
data indicate that adding cholesterol to cell membranes induces
mitotic defects in the form of aneuploidy likely affecting all
chromosomes.
2. WsCh induces trisomy 16 in mouse neuronal precursor cells.
Induction of chromosome mis-segregation by altered membrane
cholesterol in AD or NPC patients is likely to be especially
detrimental during neurogenesis and/or neuro-regeneration.
To investigate the effect of cholesterol on the development of
aneuploidy in neuronal precursor cells, we prepared neurospheres
from prenatal brains of nontransgenic mice, treated them with
WsCh, and performed FISH for chromosome 16 as described.
Parallel cultures were incubated with or without WsCh for 7 days
(equivalent to the two cell divisions used previously for the
hTERT-HME1 cells), with fresh cholesterol-containing media
being replenished every other day to allow for expansion of the
spheres, a sign of neuronal precursor cell proliferation [77]. We
observed .4% trisomy 16 in untreated cells (Figure 6C), as has
been previously reported in developing and adult normal human
and mouse brains [78–80] and a significant 2-fold increase in
trisomy 16 in cholesterol treated cells (Figure 6C).
Changing membrane fluidity by ethanol attenuates
lipoprotein-induced chromosome mis-segregation. The
fact that the addition of cholesterol to cells induces chromosome
mis-segregation is a potentially important indicator of its
underlying mechanism of action. It is well established that
membrane cholesterol content is directly proportional to mem-
brane stiffness/rigidity [81], which can be increased by cholesterol
enrichment or decreased by cholesterol depletion [82]. In contrast,
ethanol (EtOH) increases membrane fluidity, with profound
physiological effects on multiple mammalian cells, including
neurons [83]. Because both lipoprotein- and MbCD-delivered
cholesterol increases membrane cholesterol content and rigidity
in vitro [81,82,84], we hypothesized that the mitotic errors induced
in cells by lipoprotein/cholesterol might be caused by increased
membrane rigidity, which could be counteracted by the
membrane fluidizing action of ethanol.
hTERT-HME1 cells were pre-treated with 25 mM of EtOH for
24 hr and further co-incubated with lipids in EtOH-containing
media. The rationales for using this concentration of EtOH were:
1) 25 mM or 0.115% corresponds to the blood alcohol levels of
moderate drinkers (1–3 drinks a day, 15–45 g) which has been
associated with a decrease in risk for CVD [85,86] and AD [87], 2)
Figure 4. LDL induces trisomy 7 in human aortic smooth
muscle cells. Quantitative FISH analysis of HASM cells showed an
increase in trisomy 7 when incubated with 20 mg/ml of LDL, but not
HDL for 48 hr.
doi:10.1371/journal.pone.0060718.g004
Figure 5. Lipoprotein-induced aneuploidy is dependent on
LDLR and independent of APP. (A) Normal human fibroblasts (NHF)
developed significantly higher levels of trisomy 7 when treated with
20 mg/ml of LDL for 48 hr compared to LDL receptor deficient human
fibroblasts obtained from the patient diagnosed with familial hyper-
cholesterolemia (FHF). (B) Quantitative FISH for chromosome 16
revealed comparable levels of trisomy 16 in primary splenocytes
derived from nontransgenic (NON) and APP knockout (APPKO) mice
upon incubation with 20 mg/ml of OX-LDL or LDL for 48 hr, indicating
that the aneugenic activity of lipoproteins is independent of a
functional APP gene and of its product Ab.
doi:10.1371/journal.pone.0060718.g005
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increased cholesterol efflux and cholesterol transport but un-
changed cholesterol synthesis have been observed in human
astrocytes in vitro at a concentration of 25 mM of EtOH in the
presence and absence of cholesterol acceptors [88], 3) 25 mM
EtOH fluidized the exofacial leaflet of the synaptic membranes
[89], 4) long-term exposure of hepatic cells to 0.5% EtOH had no
effect on LDLR expression or the uptake of LDL [90], and 5) our
pilot experiments showed low cytotoxicity and up to ,95% cell
viability after 48 hr of 25 mM EtOH exposure and only a small,
non-significant induction of aneuploidy for chromosome 21
(HSA21) (Figure S1A–D).
Quantitative FISH analysis of lipoprotein/EtOH-treated cells
showed a significant decrease in OX-LDL and LDL-induced
trisomy 21 (Figure 7A), and trisomy 12 (Figure 7B) compared to
cells exposed only to lipoproteins, indicating that fluidization of the
membranes by EtOH stabilizes chromosome segregation upon
lipid treatment.
Extracellular Ca++ is required for lipoprotein-induced
chromosome mis-segregation. It has been postulated that
perturbed calcium homeostasis plays an important role during
aging and in AD pathogenesis, and calcium is essential for the
function of many enzymes, for example CamKII [91]. In our
recent study of Aß-induced aneuploidy, we showed that chelation
of extracellular Ca++ with BAPTA prevents chromosome mis-
segregation in vitro [23].
To elucidate whether Ca++ plays a role in lipoprotein/
cholesterol-induced aneuploidy, as it does in Aß-induced aneu-
ploidy, we conducted experiments with hTERT-HME1 cells using
two different chelating reagents, EGTA and BAPTA. First, the
cells were pre-treated with 1.5 mM of EGTA for three minutes
before incubation with 20 mg/ml of lipoproteins for 48 hr, then
analyzed by FISH. EGTA reduced by 3-fold the OX-LDL
induced trisomy 21 (Figure 8A), and tetrasomy 21 and 12
(Figure 8B). The change in mitotic index between EGTA-treated
cells with or without lipids (e.g. LDL) was not significant (107629
vs. 81642, p = 0.77, respectively).
hTERT-HME1 cells were also pre-incubated with another
Ca++ chelator, BAPTA for three minutes and then co-treated with
lipids for 48 hr. The results showed a statistically significant
BAPTA-dependent reduction in OX-LDL-induced trisomy 21
and 12 (Figure 8C), and a borderline decrease in trisomy 21 in
Figure 6. Increased membrane cholesterol induces aneuploidy.
(A,B) Karyotype and FISH analysis showed an increase in total
aneuploidy (A) and trisomy 21 and trisomy 12 (B) in hTERT cells treated
for 48 hr with 4 mg/ml cholesterol made water-soluble in a methyl-b-
cyclodextrin (MbCD) complex. (C) Mouse chromosome 16 DNA probe
was used to measure aneuploidy levels in mouse neuronal precursor
cells (mNPC) derived from prenatal brains of wild-type mice (E17–18)
and incubated with and without 4 mg/ml of WsCh for 7 days.
Quantitative FISH analysis showed a 2–fold increase in trisomy 16 in
WsCh-treated cells compared to controls. mNPC harbored up to 4.6%
endogenous aneuploidy, as reported previously in developing mouse
and human brains [73].
doi:10.1371/journal.pone.0060718.g006
Figure 7. Ethanol attenuates lipoprotein-induced chromosome
mis-segregation. (A,B) Quantitative FISH analysis of hTERT cells pre-
treated with 25 mM of ethanol (EtOH) for 24 hr and co-incubated with
lipoproteins and EtOH for an additional 48 hr revealed a decrease in
OX-LDL and LDL-induced trisomy 21 (A) and trisomy 12 (B).
doi:10.1371/journal.pone.0060718.g007
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LDL-treated samples (p = 0.065; Figure 8C). Quantification and
comparison of mitotic indices in BAPTA-treated hTERT cells
with or without lipids (e.g., LDL) revealed no significant difference
in number of metaphases per slide (67618 vs. 69637, p = 0.92,
respectively), indicating that extracellular calcium chelation does
not affect the progression of the cells through the cell cycle.
Cholesterol treatment does not cause DNA
damage. Aneuploidy is characteristic of transformed cells and
has been hypothesized to play an essential role in carcinogenesis
[92]. Radiation, DNA-damaging chemicals, or genetic mutations,
for example affecting mis-match repair, can lead to double strand
breaks in genomic DNA [93], which has been shown to lead to
chromosome mis-segregation and aneuploidy. However, we found
no increase in double strand breaks as assessed by 53 BP1
immunocytochemistry after 48 hr treatment of hTERT cells with
water-soluble cholesterol (Figure 9).
Cholesterol disrupts the mitotic spindle. There are many
mechanisms by which genes or agents can induce chromosome
mis-segregation [94]. For example, in Aß-treated cells and
Xenopus egg extracts, the mitotic spindles become shortened
and bent and the DNA becomes delocalized [24]. We treated
hTERT-HME1 cells with 4 mg/ml WsCh for 24 hr and analyzed
the mitotic spindles after staining with a-tubulin and c-tubulin
antibodies. As shown in Figure 10, cholesterol induced a multitude
(30%) of aberrant mitotic/microtubule structures with disarrayed
microtubules and displaced DNA being particularly prominent in
mitotic structures.
Discussion
We report a set of findings that reveal a novel cholesterol-
dependent cell cycle defect that may be involved in the
pathogenesis of Nieman-Pick C1 Disease, Alzheimer’s Disease
and cardiovascular disease/atherosclerosis. Specifically: 1) Medi-
um-term exposure to dietary cholesterol induces chromosome mis-
segregation in peripheral tissues of young wild-type mice, 2)
Disturbance in intracellular cholesterol homeostasis and obstruct-
ed cholesterol trafficking to the plasma membrane in NPC-1
patients is associated with an 4 to 6-fold increase in the proportion
of trisomy 21 fibroblasts, neurons and glia, 3) Atherogenic
lipoproteins (i.e., LDL, OX-LDL) and cholesterol, but much less
so the protective HDL, induce chromosome mis-segregation,
including trisomy HSA12, HSA21, and HSA7 and MMU16 in
primary human and mouse cells in vitro, 4) Lipoproteins apparently
require a functional LDL receptor but not the presence of the APP
gene to exert their aneugenic effect, 5) Cholesterol exposure
disrupts the mitotic spindle and induces disarrayed microtubules
and displaced DNA, and 6) Reduction in either plasma membrane
fluidity or Ca++ homeostasis decreases lipoprotein/cholesterol-
induced aneuploidy in vitro.
Aneugenic Effect of Lipoproteins and Cholesterol:
Implications for AD and NPC
The present data complement and extend previous work
showing that up 30% of AD human and mouse neurons and
other cells are aneuploid due to either environmental or
complex genetic influences. Although cholesterol and other
aneugens, such as mutant PS or APP genes or the Aß peptide,
affect all chromosomes in cultured cells, the lack of selection
against trisomy 21 neurons probably accounts for their
preponderance in AD and NPC-1 brain. The finding that
LDL/cholesterol induces chromosome mis-segregation in the
absence of APP indicates that the aneugenic pathways initiated
by Aß and LDL are, at least in their early steps, separate and
independent. While our analyses of actively dividing peripheral
cells and precursor brain cells were limited to a few human and
only one validated mouse chromosome probe, a comprehensive
investigation of other peripheral and brain cells (i.e., neurons
and glia) is warranted to fully understand the rate and type of
chromosome instability in relation to changed cholesterol
homeostasis.
Although there is some indication that aneuploid neurons
develop normally in human brains, possibly increasing neuronal
diversity [17,95], the large number of aneuploid neurons in AD
and NPC must arise from mitosis, either from disease-related
neurogenesis, from reactivation of the cell cycle in normally-
post-mitotic neurons, or both. A number of studies reported
Figure 8. Role for Ca++ in lipoprotein induced chromosome
mis-segregation. (A–C) Quantitative FISH analysis with a dually
labeled DNA probe for chromosomes 21 and 12 showed a significant
reduction in trisomy 21 (A), tetrasomy 21 and tetrasomy 12 (B) in hTERT
cells pre-treated with 1.5 mM of Ca++ chelator EGTA followed by OX-
LDL compared to cells treated only with OX-LDL. Cells pre-treated with
1 mM BAPTA had significantly lower levels of OX-LDL-induced trisomy
21 and trisomy 12 (C) compared to the cells grown without chelator.
doi:10.1371/journal.pone.0060718.g008
Cholesterol and Chromosome Mis-Segregation
PLOS ONE | www.plosone.org 9 April 2013 | Volume 8 | Issue 4 | e60718
neuronal aneuploidy and tetraploidy of several chromosomes in
the human brains diagnosed with AD [17,18,20,21]. Here we
did not observe a cholesterol-dependent increase in tetraploid
cells (i.e., cells that had duplicated every chromosome, but failed
to divide, or had not yet divided), but mitosis specific epitopes
have been observed in a small number of neurons in AD and
NPC brain or in mouse models of AD, and have been
interpreted as indicative of such reactivation of the cell cycle
and the consequent development of aneuploid neurons
[25,27,28,53–64]. However, the frequency of such tetraploid
(4 n) neurons in AD is certainly less than 10% of the frequency
of aneuploidy cells (with DNA content between 2 n and 4 n)
[21], and some researchers report that the number of tetraploid
cells is actually the same in brains from AD and control
individuals and are exclusively non-neuronal [96]. Nevertheless,
if neurons are induced to re-enter the cell cycle in response to
neurodegenerative disease, the resulting mitosis and cell division
might well be abnormal and result in the observed increase in
aneuploidy, rather than tetraploid neurons.
While we failed to observe a change in ploidy in the brains of
mice fed a high cholesterol diet, possibly due to the 1) length of
dietary exposure, 2) reduced neurogenesis, 3) young age of the
mice, and 4) low or nonexistent exchange of cholesterol and its
metabolites across the intact blood-brain barrier (BBB), a
peripheral induction of trisomy 16 in mitotically active tissues
may be an initiating event that precedes the induction of brain
aneuploidy once the extracerebral damage reaches a critical point
and the BBB is compromised.
In conclusion, AD and NPC1 exhibit cell cycle abnormalities, to
which excess lipoproteins, particularly LDL, can contribute and
lead to the chromosome mis-segregation, aneuploidy and neuro-
degeneration observed in these diseases. Furthermore, the fact that
aneuploid neurons also characterize other cognitive brain diseases,
such as Frontotemporal Dementia [97] (also Granic et al.,
unpublished), Down syndrome and Ataxia-Telangiectasia [20],
suggests that chromosome mis-segregation and the development of
aneuploidy neurons may be a general feature of neurodegenera-
tion.
Chromosome Instability in Atherosclerosis: Implications
for AD
Several studies have reported the hyperproliferation of aneu-
ploid smooth muscle cells within atherosclerotic plaques [45–52],
which our data suggest may be induced by elevated LDL-
cholesterol. Specifically, during the initiation of atherosclerosis, a
single smooth muscle cell that, as a consequence of aneuploidy,
suffers altered gene regulation may lose checkpoint control or
become more responsive to autocrine or paracrine growth factors
(for example by becoming trisomy for chromosome 7, which
encodes the PDGF receptor) and then hyper-proliferating to
generate the observed thickening of the vascular wall. The fact
that aneuploid cells are prone to apoptosis fits this model well, for
apoptosis of smooth muscle cells is thought to be an essential
contributor to the formation of atherosclerotic plaques [98].
Cholesterol induced aneuploidy would also be expected to initiate
atherosclerosis in the brain, which can lead to the reduced blood
flow and the development of ‘vascular dementia’ often seen AD
patients [40–43,99,100].
Furthermore, the fact that inheritance of the ApoE e4 allele is the
strongest known risk factor for developing sporadic AD other than
age [101] (i.e., ApoE being the major cholesterol carrier protein in
the brain [102]), also strengthens the potential significance of
lipoprotein/cholesterol-induced aneuploidy for the pathogenesis of
AD. LDL and ApoE4 also promote atherosclerosis [103], which is
characterized by hyperproliferation of aneuploid cells, as discussed
above [45–52], extending the connection between lipid-induced
aneuploidy and both CVD and AD. Finally, the fact that Aß
causes chromosome mis-segregation and aneuploidy [23] and that
atherosclerosis arises in the AD brain and in mouse models of AD
[40,104] suggests that Aß itself may trigger the mis-segregation
event that initiates the atherogenic process in AD.
Figure 9. Cholesterol does not cause DSBs in hTERT-HM1 cells. (A) hTERT-HME1 cells were exposed to 4 mg/ml of cholesterol for 48 hr and
immunostained for a double-strand breaks (DSBs) marker, the p53 binding protein 53 BP1. Immunofluorescent 53 BP1 (green) foci in nuclei (DAPI,
blue) of control and cholesterol-treated cells were counted. (B) There was no statistically significant (p = 0.06) increase in DSBs events ($3 foci per
nucleus) in cholesterol-treated compared to untreated cells. The nuclei containing $4 foci were extremely rare.
doi:10.1371/journal.pone.0060718.g009
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Figure 10. Mitotic spindle structure disrupted by cholesterol. (A) hTERT cells were treated for 24 hr with 4 mg/ml WsCh and the structure of
the mitotic spindles observed and analyzed for abnormal DNA localization, lagging chromosomes, super-numerary centrosomes, and dis-arrayed
microtubules. There was a significant increase in abnormal mitotic spindle structure induce by cholesterol exposure, with dis-arrayed microtubules
and mis-localized DNA being the most prominent defects. (B) Examples of normal spindles in untreated cells and abnormal spindles in cholesterol-
treated cells.
doi:10.1371/journal.pone.0060718.g010
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Mechanisms by which Aneuploidy may Contribute to
Neurodegeneration in AD
There are several ways in which cholesterol (or Aß)-induced
aneuploidy may contribute to cognitive decline in AD and
related disorders. The most straightforward mechanism would
be that aneuploid cells, with their altered genetic complements
and thus altered gene expression are inherently prone to
apoptosis/degeneration, as has been shown in many experi-
mental systems [21,105–107]. Indeed, as discussed above, the
specific loss of (especially of non-trisomy 21) aneuploid neurons
accounts for 90% of neurodegeneration in AD [9–23]. When
the aneuploid neuronal progenitors and neurons harbor trisomy
21 or 16 and accumulate in the brains of AD patients and FAD
transgenic mice respectively, overexpression of APP and other
chromosome 21/16 genes will occur. That such imbalance may
further contribute to disease onset and progression is evident in
individuals harboring trisomy 21 mosaicism [25,34–37] or an
APP gene duplication [32,33]. Similarly, the reduced neurogen-
esis and reduced neuronal number in Down syndrome [108],
may result from the constitutive over expression of APP and
production of Aß and the consequent induction of the cell cycle
defect of chromosome mis-segregation.
Another possibility supported by the data, is that, like Aß,
cholesterol disrupts chromosome segregation through inhibition
of normal MT function. In addition to inducing defective
neurogenesis as we demonstrate above, MT dysfunction could
also affect neuronal plasticity. For example, we have found that
Aß causes chromosome mis-segregation directly by binding to
and inhibiting certain MT-dependent kinesin family motor
proteins that are essential for mitotic spindle function [24].
These enzymes are also present in neurons, where they direct
plasma neurotransmitter and neutrophin receptor localization
and function at the plasma membrane [Ari et al. unpublished
data]. As altered cholesterol homeostasis also disrupts microtu-
bule structure and function, it could similarly affect receptor
localization.
Finally, the counteracting effect of ethanol on lipid-induced
chromosomal instability in vitro supports the hypothesis that the
chromosome mis-segregation induced by lipoproteins is attribut-
able to the increased membrane rigidity induced by cholesterol.
We hypothesize that membrane stiffness upon cholesterol expo-
sure may be restored by the fluidizing action of ethanol, making
the cell less prone to mitotic errors. The fluidizing effect of ethanol
on cell membranes is well established [83,88,89] and was proposed
here as a possible mechanism for the reduction in aneuploidy in
the cells co-incubated with cholesterol and alcohol, although no
measurements of membrane fluidity were employed. Significantly,
Aß peptide also increases membrane rigidity [109]. In the light of
these data and the finding of aneuploid cells in AD brain and
atherosclerotic plaques discussed above, it is interesting that
moderate ethanol consumption has been linked to reduced risk of
both CVD and AD [85–87,110]. Prospective studies of microtu-
bule stabilizers and/or ethanol or other modifiers of membrane
fluidity may open new approaches to the prevention of neurode-
generative and cardiovascular disease.
Conclusion
In this study we have presented in vitro and in vivo evidence that
cholesterol dyshomeostasis, a common risk factor for NPC-1 and
two age-related diseases (i.e., AD and atherosclerosis) may exert its
pathogenic effect in part through disruption of the cell cycle.
Specifically lipoprotein/cholesterol-induced chromosome instabil-
ity/mis-segregation may be an underlying cytogenetic trait and
part of the pathogenic pathway of multiple disorders, which opens
new avenues for research and therapy.
Materials and Methods
Cell Line
hTERT-HME1 cells. The hTERT-HME1 cell line (Clon-
tech) is a primary human mammary epithelial cell line that
permanently expresses the telomerase reverse transcriptase and
can thus divide indefinitely while retaining normal function,
phenotype, and karyotype [111,112]. The cell line was cultured in
supplemented Mammary Epithelium Basal Medium (MEBM,
Lonza) as described elsewhere [23].
Primary Cells
HASMC. Human Primary Aortic Smooth Muscle Cells
(HASMC) were isolated from healthy human aorta and cryopre-
served as secondary culture at the density .56105 cells per vial
(ScienCell Research Laboratories). The cells were maintained in
the Smooth Muscle Cell Medium according to manufacturer’s
specifications (SMCM; ScienCell Research Laboratories). Cells
are subcultured when they were 90% confluent in 2 mg/ml poly-L-
lysine (Sigma)-coated cell culture dishes.
Human fibroblasts. LDL receptor-negative human skin
fibroblasts harboring two mutations, C240-F and Y160-ter, which
cause a severe form of familial hypercholesterolemia (FH),
fibroblasts with functional LDL receptor, four different human
fibroblasts harboring NPC1 mutations and four age-matched
controls were obtained from Coriell Cell Repositories and cultured
according to their recommended protocol.
Generation and maintenance of mNPCs. Mouse neuro-
sphere cultures and derived neuronal precursor cells were
established from non-transgenic prenatal brains (E17–E18)
following a modified protocol by [77] and maintained according
to [113].
Mouse splenocytes and brain cells. Mouse spleens and
brains were harvested and processed to yield a cell suspension and
prepared for karyotype and FISH analysis according to procedures
previously described [22,23].
Human brain cells. Frozen samples of frontal cortices from
patients with the Niemann-Pick type C1 disease (age 20.8868.64)
and age, gender and race matched control brain tissues (age
17.26611.07) were obtained from the NICHD Brain and Tissue
Bank for Developmental Disorders at the University of Maryland
(Baltimore, MD). Cell suspensions were prepared as previously
described for mouse brains [23] and processed for FISH. Filipin
and NeuN co-immunolabeling revealed significantly more choles-
terol staining in the intracellular compartment in NPC neurons
compared to controls.
Mice, Feeding and Diets
Housing of and procedures involving all animals, including the
time-pregnant C57BL/6 mice were approved by the USF
Institutional Animal Care and Use Committee.
Wild-type mice. Eight one-month-old nontransgenic
C57BL/6 mice (4 males and 4 females) (Jackson Lab) were caged
in standard housing in pairs, and were fed ad libitum for 12 weeks
with either regular chow, or high cholesterol diet (Harlan
Laboratories) with free excess to fresh water. Food intake and
weight gain were monitored and recorded weekly. The mice were
anesthetized with i.p. injection of sodium pentobarbital (50 mg/kg
weight), and the tissues harvested and inspected for pathological
changes. Mice from dietary intervention were transcardially
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perfused with 0.9% saline before internal organs of interest were
removed.
Diets. Regular mouse chow (2018 Tekland Global 18%
Protein Rodent Diet, Harlan Laboratories) contains 5% crude
plant-based oil (fat), 0% cholesterol, and supplies 3.3 Kcal/g of
Digestible Energy (DE). Custom-made high cholesterol diet
(TD.95286, Harlan) consists of 21% milk fat (fat and 0.05%
cholesterol), 1% of cholesterol, and provides 4.5 Kcal/g of DE.
APPKO mice. Mice lacking an APP gene and their non-
transgenic littermates were 3–4 months of age (Jackson Labs) and
had C57BL/6 background strain. The spleens were used for
primary cell cultures and lipoprotein/cholesterol treatments.
Reagents and Kits
Lipoproteins. Human oxidized LDL (protein concentration
2 mg/ml), human LDL (protein concentration 5 mg/ml) and
human HDL (protein concentration 10 mg/ml) were purchased
from Biomedical Technologies Inc. Water-Soluble Cholesterol
(WsCh) (Sigma; 31.8 mg of pure cholesterol in 0.6 g total weight
of solid, balanced in methyl-beta-cyclodextrin) was resuspended in
sterile water.
Other reagents, kits and DNA probes. EGTA (Sigma) and
BAPTA (Calbiochem) were used as Ca++ buffering reagent at
1.5 mM and 1 mM, respectively. hTERT-HM1 cells are cultured
in medium that has 2.65 mM calcium. Absolute (without benzene)
ethyl alcohol (Sigma-Aldrich) was prepared as a sterile aqueous
1 M solution and aliquoted. Filipin complex (Sigma) was dissolved
in DMSO (Sigma) and stored at 220uC in small aliquots and
protected from light. Giemsa stain (Gibco/Invitrogen) was diluted
freshly in 1X GURR buffer (GibcoBRL Life Technologies) to stain
metaphase chromosomes. Mouse anti-neuronal nuclei (NeuN)
AlexaFluorH antibody (Millipore) and VectaShield with DAPI
(Vector Laboratories) was used to label neurons and nuclei,
respectively. Anti-53BP1 rabbit polyclonal (Abcam) and Alexa-
Fluor 488 goat-anti-rabbit antibody (Invitrogen, Molecular
Probes) were used to detect DNA double-strand breaks (DSBs)
foci, anti-a-tubulin (clone B-5-1-2, Sigma) and AlexaFluor
488 goat-anti-mouse antibodies (Invitrogen) were used to stain
mitotic spindles, and anti-c-tubulin (Sigma) and AlexaFluor
594 goat-anti-rabbit antibodies (Invitrogen) were utilized to detect
centrosomes. Nick Translation Kit (Roche) and Spectrum Green
or Spectrum Orange dUTPs (Vysis) were used to generate the
chromosome 16 BAC probe as previously described [22]. Ethanol
Assay Kits (BioVision) and BioTek Synergy HT micro-plate
reader (BioTek Instruments) for colorimetric assay (O.D. 570 nm),
and Gen5TM (BioTek Instruments) data analysis software were
used to measure ethanol concentration in the media at baseline,
after 24 and 48 hr of exposure following manufacturer’s instruc-
tions. Oil-Red-O staining kit (American MasterTech) was used to
stain for neutral lipids accumulation in mouse hepatocytes.
Fluorescently labeled DNA probes detecting human chromosome
21, 12, and, 18, 14 and 7 (LSIH TEL/AML1 ES Dual Color
Translocation Probe, LSIH IGH (14q32)/MALT1(18q21) Dual
Color Dual Fusion Probe and LSIH D7S522 (7q31) SpectrumOr-
ange TM/CEPH 7 SpectrumGreenTM, respectively) were pur-
chased from Abbott, Vysis.
In Vitro Incubation with Lipoproteins/Cholesterol
Two days prior to treatment/incubation, freshly passaged
hTERT cells (1–36105 cells/2 ml) were plated in 100 mm tissue
culture dishes in MEBM to assure 60%–70% confluency on the
day of the treatment. The cells were then incubated for 48 hr at
the concentration of 20 mg/ml of lipoproteins or 2 and 4 mg/ml of
WsCh.
Seven parallel experiments were used to assess the effect of
lipoproteins on chromosome segregation (i.e., karyotype analysis
and chromosome specific aneuploidy) and six separate experi-
ments to test the aneugenic effect of cholesterol. The same cell
passages were used for the set of parallel experiments involving
Ca++ chelating reagents, BAPTA or EGTA performed as in [23].
Similarly, two days before lipid treatment, freshly passaged
HASMC, human fibroblasts with and without a functional LDL
receptor or hTERT-HME1 cells were seeded onto pre-coated
(2 mg/ml of poly-L-lysine, Sigma) single glass chamber slides
(8.6 cm2 growth surface/well) (BD Bioscience) at the density of
100,000 and 200,000 cells per slide respectively. After 24 or 48 hr
of lipid/cholesterol incubation, the cells were rinsed twice with 1X
PBS without Ca and Mg (Cellgro), immediately fixed with either
cold 3:1 anhydrous methanol and acetic acid fixative or methanol,
and incubated at 220uC for 30 min.
Mouse non-transgenic and APPKO spleen cells were similarly
incubated with lipoproteins for 48 hr, harvested and fixed for
FISH analysis as described [22,23].
In Vitro Ethanol and Lipoprotein/Cholesterol Incubation
To assure an exact and consistent ethanol (EtOH) concentration
in treated cells, we used a modified closed chamber system
protocol by Adickes et al. [114]. Prior to ethanol and lipoproteins
co-treatments, several pilot experiments were conducted to
examine the viability of hTERT-HME1 cells in the closed
chamber, and to establish cytotoxicity of 25 mM and 50 mM of
EtOH for 6, 12 and 24 hr on cell morphology, proliferation and
survival (Trypan Blue dye exclusion). Based on these results,
triplicate experiments were conducted with 25 mM EtOH for
24 hr followed the next day by lipoproteins (20 mg/ml) and WsCh
(4 mg/ml) and EtOH co-incubation for 48 hr. A small aliquot of
EtOH containing media from two samples was collected at the
baseline, 24 and 48 hr to measure alcohol concentration using
colorimetric assay (Ethanol Assay Kit, BioVision). Lastly, the cells
were harvested and fixed for FISH analysis.
Metaphase Chromosome Analysis
After colcemid treatment, hTERT-HME1 cells were harvested
and the metaphase chromosomes counted as described [22,23].
Genus 2.81H software was used for chromosome analysis (Applied
Imaging). At least 40–45 metaphases were analyzed per each
sample.
Fluorescence in situ Hybridization (FISH)
Prior to hybridization, all slides were aged at room temperature
followed by hybridization procedures recommended by Abbott,
Vysis and by protocols and mouse and human probes described
above and previously [22,23]. Hybridizations were done according
to manufacturer’s instructions (Abbott, Vysis) for the selected
probes in a HyBrite hybridization chamber (Vysis) followed by
DAPI II (Abbott, Vysis) or Vectashield with DAPI (Vector
Laboratories) counterstain.
FISH Followed by Immunocytochemistry of NPC1 Brain
Cells
To assess neuronal versus glial cell aneuploidy in NPC1 and
control brains, we used a combination of FISH and immunocy-
tochemistry [23]. Briefly, immediately after FISH, brain cells were
incubated in 1XPBS for 10 min, blocked in 10% goat serum/
0.1% Triton X-100 PBS solution for 1 hr followed by overnight
incubation in conjugated Ms X Neuronal Nuclei AlexaFluor 488
(Millipore) 1:100 antibody prepared in 1% BSA/0.1% Triton X-
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100 1XPBS. After final washes in 1XPBS, the cells were stained
with DAPI II counterstain.
Immunocytochemical Quantification of Double Strand
Breaks
Double strand breaks, an indication of DNA damage were
identified in cholesterol-treated hTERT-HME1 cells by immuno-
staining for 53 BP1-containing foci. First, cell pellets were fixed in
70% cold ethanol, dropped onto Frosted slides (Fisher Scientific)
and air-dried. Second, immediately after fixation in 4% parafor-
maldehyde for 10 min, and three 1XPBS washes, the cells were
permeabilized in 0.2% Triton X-100 1XPBS solution for 10 min,
blocked in 5% BSA 1XPBS/0.1% Tween-20 for 30 min, and
incubated in 1% BSA 1XPBS/0.1% Tween-20 solution contain-
ing anti-53 BP1 rabbit polyclonal antibody (Abcam), 1:400 for
1 hr followed by AlexaFluor 488 goat-anti-rabbit antibody (In-
vitrogen), 1:300 incubation for the same time period. After several
1XPBS washes, the cells were stained with DAPI II (Vector).
Immunocytochemistry for Spindle Analysis
Upon fixation in methanol, cholesterol treated hTERT-HME1
cells were co-immunostained for mitotic spindles and centrosomes
with anti-a-tubulin (Sigma) and anti-c-tubulin antibodies (Sigma)
1:1000, followed by AlexaFluor 488 goat-anti-mouse and Alexa-
Fluor 594 goat-anti-rabbit secondary antibodies (Invitrogen,
Molecular Probes), 1:2000 incubation, respectively and Vecta-
shield mounting medium with DAPI staining (Vector) as described
[23].
Oil-Red-O Staining
Cell suspension of snap-frozen livers (2 from mice fed a regular
and 2 from mice fed a high cholesterol diet) were made in 1XPBS,
dropped onto pre-wetted slides, and stained with the Oil-Red-O
staining kit following manufacturer’s procedures for frozen tissues
with slight modifications (American MasterTech). Hematoxylin
stained single cells and cell aggregates (blue) were evaluated under
phase microscopy (Zeiss Imager M1) for the presence of lipid
droplets (red).
Image Acquisition and Analysis
FISH hybridization signals were analyzed according to Abbott/
Vysis guidelines as described in [22,23] using a Nikon Eclipse
E1000 fluorescence microscope with a 4912 CCIR high perfor-
mance COHU CCD Camera and Genus 2.81H software (Applied
Imaging) or a Zeiss Imager M1 microscope with a CV-M4+CL
high resolution camera and Axiovision4.6 software (Zeiss) or a
Zeiss Axiovert 135 with AxioCam HRc (Zeiss). The frequencies of
nuclei containing 0, 1, 2 or 3 53 BP1 signals were recorded in
treated and control cells, and mitotic spindle phenotypes were
analyzed as described [22]. On average, between 700 and 1,000
interphases per each sample/treatment were scored for aneuploi-
dy, and 400 NeuN positive and NeuN negative NPC1 brain cells
were analyzed for DNA hybridization signals. More than 450–600
cells for each of three samples of both WsCh-treated and control
were assessed for 53 BP1 foci, and more than 45–80 spindles from
each of four samples of both treated and control cells were
analyzed for spindle abnormalities.
Hematoxylin and Oil-Red-O stained mouse hepatocytes and
cell aggregates from mice fed a regular and high cholesterol diet
were compared and contrasted for amount of red staining under
phase microscopy (Zeiss).
Statistical Analysis
Paired Student’s T-test was used to compare the aneuploidy
induced by various lipoproteins with or without Ca++ chelating
reagents and ethanol in different cell lines across multiple
experiments and in spleen and brain cells of mice fed different
diets, and to compare the percentages of nuclei containing 1 to
3 DSBs foci and the levels of abnormal spindle events between
treated and untreated cells. Independent T-test was used to
compare the aneuploidy between NPC1 fibroblasts and NPC1
brain cells and appropriate controls. Three to 7 treatments with
lipids/cholesterol for each cell line, and triplicate experiments with
chelators and ethanol were conducted and scored for aneuploidy.
Four to 5 primary NPC1 cells sources and controls and at least 6–
12 mice were analyzed for each graph.
Ethics statement. All experiments were carried out in
accord with the University of South Florida guidelines for
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Supporting Information
Figure S1 25 mM of Ethanol (EtOH) does not induce
aneuploidy within 48 hr. hTERT-HME1 cells were treated
with 25 mM EtOH for 24 and 48 hr in a closed chamber system.
(A) No induction of trisomy 21 (or trisomy 12) was observed, but
there was an increase in tetrasomy 21 (presumably cells in G2),
within 24 hr (B). After further incubation in EtOH-containing
media, levels of such tetrasomy 21 cells returned to background
(C–D).
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